OHSU

News from the American Society of Hematological Conference in San Francisco: Updates on CML

12/6/2008 - Webcast

Guests Include:

Expert:
Michael Deininger, M.D., Ph.D.
Associate Professor of Hematology/ Medical Oncology
Oregon Health & Science University

Joining OHSU in 2002, Dr. Deininger`s clinical interests concentrate on bone marrow transplantation and leukemia. His research focuses on the molecular basis of resistance to imatinib mesylate in patients with chronic myelogenous leukemia.

Download MP3 Listen to Streaming Audio Download Transcript